Helicobacter pylori infection in children: Management and pharmacotherapy

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 4, 2008, Pages 577-585

  Sabbi, Tamara ^a   De Angelis, Paola ^a   Dall'Oglio, Luigi ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Children; Diagnosis; Therapy

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; TETRACYCLINE; TINIDAZOLE; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ANTIBIOTIC RESISTANCE; ANTIBODY BLOOD LEVEL; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CHILD; CLINICAL PROTOCOL; DISEASE ASSOCIATION; ERADICATION THERAPY; FECES ANALYSIS; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; IRON DEFICIENCY ANEMIA; LOWEST INCOME GROUP; MALNUTRITION; PATIENT COMPLIANCE; PEPTIC ULCER; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALIVA ANALYSIS; SEROLOGY; TREATMENT FAILURE; UREA BREATH TEST; WATER SUPPLY; WORK ENVIRONMENT; ADOLESCENT; DRUG ADMINISTRATION; DRUG EFFECT; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROBIOTICS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 40649096604     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.4.577     Document Type: Review

References (100)

1. Gold BD, Coletti RB, Abbott M, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7
2. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report. Gut 2007;56(6):772-81
3. Gasbarrini A, Franceschi F, Armuzzi A, et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999;45(Suppl I):I9-I2
4. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16(Suppl 1):3-15
5. Czinn SJ. Helicobacter pylori infection: detection, investigation and management. J Pediatr 2005;146(3 Suppl):S21-6
6. Cataldo F, Simporè J, Greco P, et al. Helicobacter pylori infection in Burkina Faso: an enigma within an enigma. Digest Liver Dis 2004;36(9):589-93
7. Dore MP, Vaira D. Sheep rearing and Helicobacter pylori infection - an epidemiological model of anthropozoonosis. Digest Liver Dis 2003;35:7-9
8. Papiez D, Konturek PC, Bielanski W, et al. Prevalence of Helicobacter pylori infection in Polish shepherds and their families. Digest Liver Dis 2003;35:10-5
9. Goodman KJ, Correa P, Tangana Aux HJ, et al. Helicobacter pylori infection in the Columbian Andes: a population-based study of transmission pathways. Am J Epidemiol 1996;144:290-9
10. Dore MP, Malaty HM, Fanciulli G, et al. Acquisition of Helicobacter pylori infection in school children in Italy. Gastroenterology 1997;112:A105
11. Dore MP, Sepulveda AR, El-Zimaity H, et al. Isolation of Helicobacter pylori infection from sheep. Implication for transmission to humans. Am J Gastroenterol 2001;96:1341-96
12. Dore MP, Sepulveda AR, Osato MS, et al. Helicobacter pylori in sheep milk. Lancet 1999;354:132
13. Drumm B, Koletzko S, Oderda G, European Paediatric Task Force On Helicobacter Pylori: Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000;30(2):207-13
14. Sherman PM. Appropriate strategies for testing ant treating Helicobacter pylori in children: when and how? Am J Med 2004;117(Suppl 5A):30S-35S
15. The European Helicobacter Pylori Study Group. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80
16. Imrie C. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373-80
17. Shepherd AJ, Williams CL, Doherty CP, et al. Comparison of an enzyme immunoassay for the detection of Helicobacter pylori antigens in the faeces with the urea breath test. Arch Dis Child 2000;83:268-70
18. Oderda G, Rapa A, Ronchi B, et al. Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ 2000;320:347-8
19. Braden B, Posselt HG, Ahrens P, et al. New immunoassay in stool provides an accurate noninvasive diagnostic method for Helicobacter pylori screening in children. Pediatrics 2000;106(1):115-7
20. Malfertheiner P, Megraud F, O'Morain C. Guidelines for the management of Helicobacter pylori infection. In: Business Briefing: European Gastroenterology Review.
21. Rubin CE. Are there three types of Helicobacter pylori gastritis? Gastroenterology 1997;112:2108-10
22. Hassal E. Unique features of Helicobacter pylori disease in children. Digest Dis Sci 1991;36:417-23
23. Cadranel S, Bontemps P, Van Biervliet S, et al. Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. Acta Paediatr 2007;96:82-6
24. Ables AZ, Pharm D, Simon I, Melton ER. Update on Helicobacter pylori treatment. Am Family Phys 2007;75:351-8
25. Pakodi F, Abdel-Salam OM, Debreceni A, Mòzsik G. Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. J Physiol Paris 2000;94:139-52
26. Alarcon T, Vega AE, Domingo D, et al. Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 2003;41:486-99
27. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. 2004;M100-S14:24(1), table 2J
28. King A. Recommendations for susceptibility tests on fastidious organisms and those requiring special handling. J Antimicrob Chemother 2001;48(Suppl 1):77-80
29. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. 2004;M100-S14:24(1), table 3A
30. Hachem CY, Clarridge JE, Reddy R. Antimicrobial susceptibility testing of Helicobacter pylori: comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin and metronidazole. Diagn Microbiol Infect Dis 1996;24(1):37-41
31. Tolia V, Brown W, El-Baba M, et al. Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan. Pediatr Infect Dis J 2000;19:1167-71
32. De Korwin JD. Helicobacter pylori infection and antimicrobial agents resistance. Rev Méd Interne 2004;25(1):54-64 (in French)
33. Jenks PJ. Causes of failure of eradication of Helicobacter pylori. BMJ 2002;325(7354):3-4
34. Kalach N, Bergeret M, Benhamou PH, et al. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J Clin Microbiol 2001;39(1):394-7
35. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20(11):820-3
36. Sabbi T, De Angelis P, Colistro F, et al. Efficacy of noninvasive tests in the diagnosis of Helicobacter pylori infection in pediatric patients. Arch Pediatr Adolesc Med 2005;159:238-41
37. Makristathis A, Hirschl AM, Lehours P, Megraud F. Diagnosis of Helicobacter pylori infection. Helicobacter 2004;19(Suppl I):7-14
38. Trevisani L, Santori S, Galvani F, et al. Evaluation of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospectives pilot study. Am J Gastroenterol 1999;94(7):1830-3
39. Falsafi T, Valizadeh N, Sepehr S, Najafi M. Application of a stool antigen test to evaluate the incidence of Helicobacter pylori infection in children and adolescent from Tehran, Iran. Clin Diagn Lab Immunol 2005;12(9):1094-7
40. Koletzko S. Noninvasive diagnostic tests for Helicobacter pylori infection in children. Can J Gastroenterol 2005;19(7):433-9
41. De Haan SN. Diagnostic methods for Helicobacter pylori infection in children. Ned Tijdschr Geneeskd 2005;149(24):1236-9
42. Pathak CM. Urea breath test for Helicobacter pylori detection: present status. Trop Gastroenterol 2004;25(4):156-61
43. Sood MR. Growth in children with Helicobacter pylori infection and dyspepsia. Arch Dis Child 2005;90(10):1025-8
44. Czinn SJ. Helicobacter pylori infection: detection, investigation and management. J Pediatr 2005;146(3 Suppl):S21-6
45. Lin MH, Chen LK, Hwang SJ, et al. Childhood functional abdominal pain and Helicobacter pylori infection. Hepatogastroenterology 2006;53(72):883-6
46. Malaty HM, Abudayyeh S, Graham DY, et al. A prospective study for the association of Helicobacter pylori infection to a multidimensional measure for recurrent abdominal pain in children. Helicobacter 2006;11(4):250-7
47. Nakajama Y, Horiuchi A, Kumagai T, et al. Psychiatric, somatic, and gastrointestinal disorders, and Helicobacter pylori infection in children with recurrent abdominal pain. Arch Dis Child 2006;91(8):671-4
48. Tindberg Y. Helicobacter pylori infection and abdominal symptoms among Swedish school children. J Pediatr Gastroenterol Nutr 2005;41(1):33-8
49. Yang YJ. Short-term recurrent abdominal pain related to Helicobacter pylori infection in children. J Gastroenterol Hepatol 2005;20(3):395-400
50. Plunkett A. Recurrent abdominal pain in childhood. J R Soc Med 2005;98(3):101-6
51. Biswal N. Helicobacter pylori and recurrent abdominal pain. Indian J Pediatr 2005;72:561-5
52. Mierzwa G, Augustynska B, Czerwionka-Szaflarska M, Tyrakowski T. Iron status with particular consideration of soluble transferrin receptors in children any youth with gastritis, with or without Helicobacter pylori infection. Pol Merkur Lekarski 2006;21(123):235-8
53. Bata G, Zielinska-Duda H, Czerwionka-Szaflarska M. Helicobacter pylori infection as a cause of sideropenic anaemia resistant to treatment - own observation. Med Wieku Rozwoj 2006;10(2):511-7
54. Aanpreung P. Suggestive parameters for eradication therapy in children with Helicobacter pylori gastritis. J Med Assoc Thai 2005;88(Suppl 8):S21-6
55. Christofides A, Schauer C, Zlotkin SH. Iron deficiency and anemia prevalence and associated etiologic risk factors in First Nations and Inuit communities in Northern Ontario and Nunavut. Can J Public Health 2005;96(4):304-7
56. Baggett HC, Parkinson AJ, Muth PT, et al. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics 2006;117(3):e396-404
57. Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 2006;163(2):127-34
58. Baysoy G, Ertem D, Ademoglu E, et al. Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection. J Pediatr Gatroenterol Nutr 2004;38(2):146-51
59. Ashorn M. Acid and iron-disturbances related to Helicobacter pylori infection. J Pediatr Gatroenterol Nutr 2004;38(2):137-9
60. Russo-Mancuso G, Branciforte F, Licciardello M, La Spina M. Iron deficiency anemia as the only sign of infection with Helicobacter pylori: a report of 9 pediatric cases. Int J Hematol 2003;78(5):429-31
61. Kostaki M, Fessatou S, Karpathios T. Refractory iron-deficiency anemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr 2003;162(3):177-9
62. Sykora J, Cernà Z, Hejda V, et al. Hypergastrinemia associated with Helicobacter pylori infection and sideriopenic anemia in a 25-years-old girl. Cas Lek Cesk 2002;141(23):739-41
63. Fallahi GH, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr 2007;74(2):127-30
64. Lopes AI, Oleastro M, Palha A, et al. Antibiotic-resistant Helicobacter pylori strains in Portuguese children. Pediatr Infect Dis J 2005;24(5):404-9
65. Kalach N, Benhamou PH, Bergeret M, et al. Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children. Arch Pediatr 2002;9(2):130-5
66. Khurana R, Fischbach L, Chiba N, et al. Meta-analysis: Helicobacter pylori eradication treatment efficacy in children. Aliment Pharmacol Ther 2007;25(5):523-36
67. Mrad SM, Boukthir S, Fdhila F, et al. Children Helicobacter pylori infection: antibiogram results. Tunis Med 2005;83(10):599-602
68. Siavoshi F, Safari F, Doratotaj D, et al. Antimicrobial resistance of Helicobacter pylori isolated from Iranian adults and children. Arch Iran Med 2006;9(4):308-14
69. Oderda G, Shcherbakov P, Bontems P, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 2007;12(2):150-6
70. Thyagarajan SP, Ray P, Das BK, et al. Geographical differences in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol 2003;18(12):1373-8
71. Kalach N, Benhamou PH, Bergeret M, et al. Acquisitin of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children. Arch Pediatr 2002;9(2):130-5
72. Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication: a randomized trial. Gastroenterology 2005;129(5):1414-9
73. Choi J, Jang JY, Kim JS, et al. Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. J Korean Med Sci 2006;21(6):1037-40
74. Lionetti E, Fico S, Maurogiovanni G, et al. Treatment for Helicobacter pylori in children. Recent Adv Recent Pro Med 2006;97(9):472-6
75. Cavallaro LG, Egan B, O'Morain C, Di Mario F. Treatment of Helicobacter pylori infection. Helicobacter 2006;11(Suppl 1):136-9
76. Arenz T, Antos D, Russmann H, et al. Esomeprazole-based 1-week triple therapy direct by susceptibility testing for eradication of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 2006;43(2):180-4
77. Faber J, Bar-Meir M, Rudensky B, et al. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? J Pediatr Gastroenterol Nutr 2005;40(5):571-4
78. Khurana R, Fischbach L, Chiba N, et al. An update on anti-Helicobacter pylori treatment in children. Can J Gastroenterol 2005;19(7):441-5
79. Bahremand S, Nematollahi LR, Fourutan H, et al. Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. Eur J Gastroenterol Hepatol 2006;18(5):511-4
80. Boyanova L, Nikolov R, Lazarova E, et al. Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adults patients over 9 years. J Med Microbiol 2006;55(Part 1):65-8
81. Masjedizadeh R, Hajiani E, Moezardalan K, et al. Helicobacter pylori infection and oesophagitis: a case control study. World J Gastroenterol 2006;12(35):5658-62
82. Kupcinskas L, Malfertheiner P. Helicobacter pylori and non-malignant diasease. Helicobacter 2005;10(Suppl 1):26-33
83. Malfertheiner P, Lind T, Willich S, et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive-oesophageal reflux disease (GORD) and symptoms resolution in non-erosive GORD: report from the ProGORD study. Gut 2005;54(6):746-51
84. Kupcinskas L, Jonaitis L, Kiudelis G. A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2004;16(4):369-74
85. Peitz U, Raps S, Plein K, et al. Long-term course of reflux symptoms following Helicobacter pylori eradication. Dtsch Med Wochenschr 2004;129(13):671-5
86. Malfertheiner P. Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease. Gut 2004;53(2):312-3
87. Wu JC, Chan FK, Ching JY, et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004;53(2):174-9
88. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53(1):12-20
89. Ayhan S, Demir MA, Kandiloglu AR, et al. Features of chronic inflammation at the gastric cardia and the relationship with Helicobacter pylori infection and oesophagitis. Acta Gastroenterol Belg 2003;66(2):144-9
90. Vucelic B, Mesihovic R, Bratovic I, et al. Helicobacter pylori infection and chronic gastritis as extraesophageal factors in gastro-oesophageal reflux disease. Med Arch 2003;57(1 Suppl 1):39-44
91. Sykora J. Current epidemiological and clinical issues regarding Helicobacter pylori infection in childhood. Epidemiol Mikrobiol Imunol 2006;55(1):3-16
92. Gotteland M. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther 2006;23(8):1077-86
93. Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002;16(9):1669-75
94. Cremonini F, Canducci F, Di Caro S, et al. Helicobacter pylori treatment: a role for probiotics? Digest Dis 2001;19(2):144-7
95. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effects of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001;15(2):163-9
96. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004;20(10):1181-8
97. Canducci F, Cremonini F, Armuzzi A, et al. Probiotics and Helicobacter pylori eradication. Digest Liver Dis 2002;34(Suppl 2):S81-3
98. Felley C, Michetti P. Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol 2003;17(5):785-91
99. Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection, Int J Antimicrob Agents 2003;22(4):360-6
100. Cremonini F, Di Caro S, Covino M, et al. Effects of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002;97(11):2744-9